Teyi Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001WK6
CNY
13.27
-1.25 (-8.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
679.70
1,054.93
876.70
748.89
624.51
910.13
872.43
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
679.70
1,054.93
876.70
748.89
624.51
910.13
872.43
Raw Material Cost
415.29
496.54
477.35
399.48
349.83
398.15
382.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
76.48
76.56
64.09
76.61
66.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.88
16.81
29.60
29.84
43.21
46.61
41.00
Selling and Distribution Expenses
199.56
216.19
155.51
137.76
132.97
246.61
242.76
Other Expenses
3.37
2.22
-7.12
-7.20
-7.35
-8.19
-6.38
Total Expenditure (Excl Depreciation)
654.44
751.76
667.69
571.62
516.64
686.12
668.69
Operating Profit (PBDIT) excl Other Income
25.299999999999997
303.2
209
177.3
107.89999999999999
224
203.70000000000002
Other Income
12.26
16.34
16.92
22.77
14.89
19.57
15.76
Operating Profit (PBDIT)
103.50
383.14
278.52
251.37
170.02
289.10
260.19
Interest
5.88
16.81
29.60
29.84
43.21
46.61
41.00
Exceptional Items
-11.63
-13.17
0.00
-23.06
-22.42
0.00
0.00
Gross Profit (PBDT)
264.40
558.39
399.36
349.40
274.68
511.98
490.29
Depreciation
63.93
60.17
52.59
51.38
51.10
45.63
42.04
Profit Before Tax
22.05
292.99
196.32
147.10
53.28
196.86
177.16
Tax
1.56
39.82
18.12
20.18
9.46
25.15
21.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.50
253.18
178.20
126.92
43.82
171.71
155.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.50
253.18
178.20
126.92
43.82
171.71
155.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.50
253.18
178.20
126.92
43.82
171.71
155.55
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
1,764.93
2,010.68
1,364.55
1,207.53
1,026.05
1,091.32
1,049.47
Earnings per share (EPS)
0.04
0.55
0.41
0.29
0.11
0.0
0.0
Diluted Earnings per share
0.04
0.55
0.41
0.29
0.11
0.0
0.0
Operating Profit Margin (Excl OI)
4.02%
29.07%
23.84%
23.67%
16.66%
24.6%
23.2%
Gross Profit Margin
12.65%
33.48%
28.39%
26.5%
16.71%
26.64%
25.12%
PAT Margin
3.02%
24.0%
20.33%
16.95%
7.02%
18.87%
17.83%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -35.57% vs 20.33% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -91.90% vs 42.09% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -75.14% vs 40.21% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -64.88% vs -43.24% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Teyi Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
679.70
0
679.70
Other Operating Income
0.00
0.00
0.00
Total Operating income
679.70
0
679.70
Raw Material Cost
415.29
0
415.29
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.88
0
5.88
Selling and Distribution Expenses
199.56
0
199.56
Other Expenses
3.37
0.00
3.37
Total Expenditure (Excl Depreciation)
654.44
0
654.44
Operating Profit (PBDIT) excl Other Income
25.26
0.00
25.26
Other Income
12.26
0
12.26
Operating Profit (PBDIT)
103.50
0
103.50
Interest
5.88
0
5.88
Exceptional Items
-11.63
0
-11.63
Gross Profit (PBDT)
264.40
0
264.40
Depreciation
63.93
0
63.93
Profit Before Tax
22.05
0
22.05
Tax
1.56
0
1.56
Provisions and contingencies
0
0
0.00
Profit After Tax
20.50
0
20.50
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
20.50
0
20.50
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.50
0
20.50
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,764.93
0
1,764.93
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
4.02%
0%
0.00
4.02%
Gross Profit Margin
12.65%
0%
0.00
12.65%
PAT Margin
3.02%
0%
0.00
3.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 67.97 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -35.57% vs 20.33% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 2.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -91.90% vs 42.09% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.12 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -75.14% vs 40.21% in Dec 2023

Annual - Interest
Interest 0.59 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -64.88% vs -43.24% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.02%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023